InvestorsHub Logo
Followers 156
Posts 6362
Boards Moderated 1
Alias Born 08/06/2004

Re: MayoMobile post# 372070

Monday, 08/29/2022 10:20:57 PM

Monday, August 29, 2022 10:20:57 PM

Post# of 460256
Mayo, I have had a question that has not been answered or opinion given that you may be able to answer since it involves a misfolded protein.

"Simufilam is Cassava Sciences’ proprietary, small molecule (oral) drug that restores the normal shape and function of altered filamin A (FLNA) protein in the brain."

Since filamin A is down stream from the S1 receptor; once Anavex 2-73 restores the S1 receptor to homeostasis, would that restore filamin A to proper folding, thus making SAVA's drug redundant and not needed?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News